Influenza vaccine, quadrivalent (Seqirus)
N/A
Report date: 2026/03/12 20:00:16
Base Information
Drug NameInfluenza vaccine, quadrivalent (Seqirus)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2018/12/12
Country/Territory +[21]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSeqirus Usa Inc
China Registration ClassN/A
Develop Information
Active CompaniesSeqirus
Inactive CompaniesSeqirus Netherlands BvNovartis VaccinesNational Institute Of Allergy And Infectious Diseases (Niaid)
Active Indications
Inactive Indications
Other Information
ATC Code
Related LinksN/A